Create Invoice

GlaxoSmithKline Slovakia - Company Information, finance statistics

Date of updating data: 02.05.2016
Basic information
Business name GlaxoSmithKline Slovakia
PIN 35734833
TIN 2020219520
VAT number SK2020219520
Date create 26 November 1997
Company category Spoločnosť s ručením obmedzeným
Registered seat GlaxoSmithKline Slovakia
Galvaniho 7/A
82104
Bratislava
Financial information
Sales and income 85 366 519 €
Profit 2 380 800 €
Capital 57 662 087 €
Own capital 43 811 861 €
Contact Information
Phone(s) 0248261111, 0248261110
Fax(es) 0248261110
Date of updating data: 02.05.2016
ASSETS 2014
TOTAL ASSETS line. 02 + r. 33 + r. 74 58,654,344
A. Non-current assets r. 03 + r. 11 + r. 21 768,253
A.I. Non-current intangible assets total (r. 04 to r. 10) 45,078
2. Software (013) - /073, 091A/ 37,578
3. Valuable rights (014) - /074, 091A/ 7,500
A.II. Non-current tangible assets total (r. 12 to r. 20) 723,175
2. Buildings (021) - /081, 092A/ 11,788
3. Separate movable assets and sets of movable assets (022) - /082, 092A/ 689,919
6. Other non-current tangible assets (029, 02X, 032) - /089, 08X, 092A/ 4,070
7. Acquired long-term tangible assets (042) - /094/ 17,398
B. Current assets r. 34 + r. 41 + r. 53 + r. 66 + r. 71 54,142,975
B.I. Total inventory (r. 35 to r. 40) 11,879,430
5. Goods (132, 133, 13X, 139) - /196, 19X/ 11,879,430
B.II. Long-term receivables sum (r. 42 + r. 46 to r. 52) 853,513
8. Deferred tax asset (481A) 853,513
B.III. Short-term receivables sum (r. 54 + r. 58 to r. 65) 17,409,263
B.III.1. Trade receivables the sum of (r. 55 to r. 57) 11,581,346
1.a. Trade receivables owed by affiliated entities (311A, 312A, 313A, 314A, 315A, 31XA) - /391A/ 4,351,044
1.c. Other trade receivables (311A, 312A, 313A, 314A, 315A, 31XA) - /391A/ 7,230,302
3. Other loans to affiliated entities (351A) - /391A/ 5,809,073
7. Tax assets and subsidies (341, 342, 343, 345, 346, 347) - /391A/ 1,657
9. Other receivables (335A, 33XA, 371A, 374A, 375A, 378A) - /391A/ 17,187
B.IV. Short-term financial assets total (r. 67 to r. 70) 24,000,000
B.IV.1. Short-term financial assets in affiliated entities (251A, 253A, 256A, 257A, 25XA) - /291A, 29XA/ 24,000,000
B.V. Financial accounts r. 72 + r. 73 769
2. Bank accounts (221A, 22X +/- 261) 769
C. Total accruals (r. 75 to r. 78) 3,743,116
2. Prepaid expenses short-term (381A, 382A) 172,197
4. Accrued income short-term (385A) 3,570,919
LIABILITIES 2014
TOTAL EQUITY AND LIABILITIES r. 80 + r. 101 + r. 141 58,654,344
A. Equity r. 81 + r. 85 + r. 86 + r. 87 + r. 90 + r. 93 + r. 97 + r. 100 48,479,305
A.I. Capital sum (r. 82 to r. 84) 21,647,614
A.I.1. Share capital (411 or +/- 491) 21,647,614
A.IV. The legal reserve funds r. 88 + r. 89 1,195,441
A.IV.1. Legal reserve fund indivisible fund (417A, 418, 421A, 422) 1,195,441
A.VII. Profit / loss from previous years r. 98 + r. 99 23,255,450
A.VII.1. Retained earnings from previous years (428) 26,560,101
2. Accumulated losses from previous years (/-/429) -3,304,651
A.VIII. Profit / loss for the accounting period after tax /+-/ r. 01 - r. 81 + r. 85 + r. 86 + r. 87 + r. 90 + r. 93 + r. 97 + r. 101 + r. 141) 2,380,800
B. Liabilities line. 102 + r. 118 + r. 121 + r. 122 + r. 136 + r. 139 + r. 140 10,175,039
B.I. Long-term liabilities total (r. 103 + r. 107 to r. 117) -487
9. Liabilities from social fund (472) -487
B.IV. Short-term liabilities total (r. 123 + r. 127 to r. 135) 8,539,565
B.IV.1. Trade payables total (r. 124 to r. 126) 7,034,364
1.a. Trade payables to affiliated entities (321A, 322A, 324A, 325A, 326A, 32XA, 475A, 476A, 478A, 47XA) 4,212,271
1.c. Other payables (321A, 322A, 324A, 325A, 326A, 32XA, 475A, 476A, 478A, 47XA) 2,822,093
6. Liabilities to employees (331, 333, 33X, 479A) 155,563
7. Liabilities from social insurance (336) 133,134
8. Tax liabilities and subsidies (341, 342, 343, 345, 346, 347, 34X) 1,216,582
10. Other liabilities (372A, 379A, 474A, 475A, 479A, 47XA) -78
B.V. Short-term provisions r. 137 + r. 138 1,604,228
B.V.1. Statutory reserves (323A, 451A) 81,257
2. Other reserves (323A, 32X, 459A, 45XA) 1,522,971
B.VI. Current bank loans (221A, 231, 232, 23X, 461A, 46XA) 31,733
Date of updating data: 02.05.2016
Income and expenses 2014
* Net turnover (part of the accounting tr. 6 according to the law) 85,366,519
** Income from the economic activity of the total sum (r. 03 to r. 09) 85,366,519
I. Revenues from the sale of goods (604, 607) 61,237,376
III. Revenues from sale of services (602, 606) 21,007,661
VI. Revenues from sales of intangible fixed assets, tangible fixed assets and materials (641, 642) 75,978
VII. Other revenues from economic activity (644, 645, 646, 648, 655, 657) 3,045,504
** The cost of economic activity along r. 11 + r. 12 + r. 13 + r.14 + r. 15 + r. 20 + r. 21 + r. 24 + r. 25 + r. 26 81,843,824
A. The costs incurred for the purchase of goods sold (504, 507) 58,387,287
B. Consumption of material, energy and other non-inventory items supplies (501, 502, 503) 709,825
C Impairment losses on inventories (+/-) (505) 1,530,413
D. Services (účtová group of 51) 11,794,617
E. Personnel expenses (r. 16 to r. 19) 5,518,561
E.1. Wages and salaries (521, 522) 3,702,775
3. The cost of social insurance (524, 525, 526) 1,417,792
4. Social expenses (527, 528) 397,994
F. Taxes and fees (účtová group of 53) 22,357
G. Depreciation and impairment losses on non-current intangible assets and tangible fixed assets (r. 22 + r. 23) 531,403
G.1. Depreciation of intangible assets and property, plant and equipment (551) 531,403
H. Residual price of sold long-term assets and material sold (541, 542) 9,518
I. Allowance for bad debts (+/-) (547) -71,949
J. Other costs of economic activity (543, 544, 545, 546, 548, 549, 555, 557) 3,411,792
*** Profit / loss from operating activities (+/-) (r. 02 - r. 10) 3,522,695
* Added value (r. 03 + r. 04 + r. 05 + r. 06 + r. 07) - (r. 11 + r. 12 + r. 13 + r. 14) 9,822,895
** Revenues from financial activities total r. 30 + r. 31 + r. 35 + r. 39 + r. 42 + r. 43 + r. 44 57,385
X. Proceeds from short-term financial assets total (r. 36 to r. 38) 2,051
X.1. Proceeds from short-term financial assets from affiliated entities (666A) 2,051
XII. Foreign exchange gains (663) 55,334
**. The cost of financial activity along r. 46 + r. 47 + r. 48 + r. 49 + r. 52 + r. 53 + r. 54 145,603
N. Interest cost (r. 50 + r. 51) 159
2. Other expense (562A) 159
O. Exchange rate losses (563) 40,093
Q. Other expenses on financial activities (568, 569) 105,351
*** Profit / loss from financial activities (+/-) (r. 29 - r. 45) -88,218
**** Profit / loss for the accounting period before tax (+/-) (r. 27 + r. 55) 3,434,477
R. Income tax (r. 58 + r. 59) 1,053,677
R.1. Income tax expense current (591, 595) 1,698,397
2. Deferred income taxes (+/-) (592) -644,720
**** Profit / loss for the accounting period after taxation (+/-) (r. 56 - r. 57 - r. 60) 2,380,800
Date of updating data: 02.05.2016
Date of updating data: 02.05.2016
  • PIN :35734833 TIN: 2020219520 VAT number: SK2020219520
  • Registered seat: GlaxoSmithKline Slovakia, Galvaniho 7/A, 82104, Bratislava
  • Date create: 26 November 1997
  • Directors:
    Person Function Registered seat Date
    Ing. Jozef Jačanin Smaragdová 3193/4 Chorvátsky Grob 900 25 29.10.2013
    Ing. Tomáš Veselý Bratislavská 1492/13 Praha 102 00 Česká republika 29.10.2013
    Ing. Romana Jourdren Nad Kazankou 217/27 Praha 7 - Troja 171 00 Česká republika 14.03.2014
    MUDr. Andrea Kočišová Kozia 9 Viničné 900 23 29.03.2016
  • Owners:
    Person Function Share Registered seat
    Setfirst Limited 0 € (0%) Brentford Middlesex TW8 9GS Veľká Británia
    • History of changes in the company and the presentation of trade registers:
      29.04.2016Nový štatutárny orgán:
      MUDr. Andrea Kočišová Kozia 9 Viničné 900 23 Vznik funkcie: 29.03.2016
      23.04.2014Nový štatutárny orgán:
      Ing. Romana Jourdren Nad Kazankou 217/27 Praha 7 - Troja 171 00 Česká republika Vznik funkcie: 14.03.2014
      16.11.2013Nový štatutárny orgán:
      Ing. Jozef Jačanin Smaragdová 3193/4 Chorvátsky Grob 900 25 Vznik funkcie: 29.10.2013
      Ing. Tomáš Veselý Bratislavská 1492/13 Praha 102 00 Česká republika Vznik funkcie: 29.10.2013
      27.04.2006Nové sidlo:
      Galvaniho 7/A Bratislava 821 04
      10.09.2005Noví spoločníci:
      Setfirst Limited 980 Great West Road Brentford Middlesex TW8 9GS Veľká Británia
      26.04.2002Nové obchodné meno:
      GlaxoSmithKline Slovakia s.r.o.
      Nové predmety činnosti:
      kúpa tovaru za účelom jeho predaja konečnému spotrebiteľovi (maloobchod) alebo za účelom jeho predaja iným prevádzkovateľom živností (veľkoobchod)
      reklamná a propagačná činnosť
      veľkodistribúcia liekov a zdravotníckych pomôcok
      koordinácia vykonávania medzinárodných klinických štúdií v Slovenskej republike
      Nový štatutárny orgán:
      konatelia
      26.11.1997Nová právna forma:
      Spoločnosť s ručením obmedzeným